Allergan has agreed to pay $13 million to settle a whistle-blower lawsuit brought by two Philadelphia-area ophthalmologists who alleged that the drugmaker engaged in a kickback scheme in order to get physicians to prescribe its eye-care medications.
Ophthalmologists Herbert Nevyas and Anita Nevyas-Wallace said that Allergan offered paid speaking engagements, free business consulting, and other services in order to stimulate sales of eye-care drugs Restasis and Acular.
Allergan agreed to pay $13 million to settle the case. The funds will be shared by Nevyas and Nevyas-Wallace, the federal government, and 19 states involved in the action.
Read the Philly.com article